Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.34B | 20.23B | 20.08B | 21.12B | 19.67B | 16.03B |
Gross Profit | 5.80B | 5.69B | 6.00B | 6.40B | 6.31B | 4.56B |
EBITDA | 2.36B | 3.55B | 3.26B | 3.62B | 3.54B | 2.48B |
Net Income | 1.42B | 984.45M | 886.44M | 1.28B | 1.35B | 448.52M |
Balance Sheet | ||||||
Total Assets | 34.89B | 38.47B | 34.77B | 33.87B | 31.61B | 27.52B |
Cash, Cash Equivalents and Short-Term Investments | 7.36B | 8.06B | 5.54B | 6.84B | 7.16B | 4.92B |
Total Debt | 1.33B | 3.27B | 1.50B | 1.44B | 1.28B | 53.13M |
Total Liabilities | 6.73B | 7.91B | 6.34B | 6.47B | 6.07B | 3.85B |
Stockholders Equity | 28.16B | 30.56B | 28.43B | 27.40B | 25.54B | 23.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -86.55M | -1.06B | -466.39M | 1.14B | 1.95B |
Operating Cash Flow | 0.00 | 2.64B | 1.43B | 2.22B | 1.91B | 2.74B |
Investing Cash Flow | 0.00 | -1.75B | -2.46B | -2.28B | -764.12M | -623.05M |
Financing Cash Flow | 0.00 | 1.41B | -548.53M | -500.37M | 881.49M | -259.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.95B | 8.58 | 0.68% | 6.51% | 3.68% | ||
81 Outperform | ¥9.51B | 10.16 | 3.62% | 9.95% | -17.59% | ||
74 Outperform | ¥9.31B | 9.46 | 4.63% | 0.75% | 12.11% | ||
74 Outperform | ¥10.23B | 11.63 | 0.52% | 9.79% | -25.96% | ||
67 Neutral | ¥9.40B | 7.98 | 2.85% | 10.57% | 4.16% | ||
67 Neutral | $2.50B | 12.40 | 9.94% | 4.60% | -2.21% | 31.02% | |
66 Neutral | ¥8.62B | 20.36 | 0.74% | 19.16% | 68.12% |